Title:
PHARMACEUTICAL COMPOSITION CONTAINING TENELIGLIPTIN
Document Type and Number:
Japanese Patent JP2022184669
Kind Code:
A
Abstract:
To provide a pharmaceutical composition containing teneligliptin hydrobromide in which an amorphous state is maintained, a pharmaceutical composition containing teneligliptin hydrobromide in which an increase in an analogous substance is suppressed, and a pharmaceutical composition containing teneligliptin hydrobromide in which a reduction in an elution rate is suppressed.SOLUTION: A teneligliptin-containing pharmaceutical composition contains amorphous teneligliptin hydrobromide, polyvinyl alcohol/acrylic acid/methyl methacrylate copolymer, and/or polyvinyl alcohol.SELECTED DRAWING: Figure 1
More Like This:
| WO/2002/079188 | PYRROLIDINE SULFONAMIDES |
| WO/2011/023626 | PYRROLIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS |
| JP5399921 | A thioxanthene derivative useful for the medical treatment of infection |
Inventors:
MATSUNAGA SAORI
Application Number:
JP2021113838A
Publication Date:
December 13, 2022
Filing Date:
June 01, 2021
Export Citation:
Assignee:
NIHON GENERIC CO LTD
International Classes:
A61K31/497; A61K9/20; A61K9/24; A61K47/02; A61K47/22; A61K47/32; A61P3/10
Previous Patent: Portable biometric authentication device by key input
Next Patent: Cane with Inclined Grip Stand
Next Patent: Cane with Inclined Grip Stand